Icosavax, Inc. Common Stock
ICVX
ICVX was delisted on the 16th of February, 2024.
73 hedge funds and large institutions have $101M invested in Icosavax, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 5 closing their positions.
556% more call options, than puts
Call options by funds: $59K | Put options by funds: $9K
320% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 5
28% more funds holding
Funds holding: 57 → 73 (+16)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
23% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 22
46% less capital invested
Capital invested by funds: $188M → $101M (-$86.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$1.56M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.5M |
| 3 |
Citigroup
New York
|
+$1.41M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$788K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$738K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$19.2M |
| 2 |
PA
Perceptive Advisors
New York
|
-$5.94M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$3.63M |
| 4 |
N
NanoDimension
Woodside,
California
|
-$2.34M |
| 5 |
Morgan Stanley
New York
|
-$596K |
ICVX Hedge Fund Activity: Q3 2022 in Review
73 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q3 2022, worth a combined $101M — down 46% from $188M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new ICVX positions and 5 closed out — a net gain of 16 holders — while 17 added to existing stakes and 22 trimmed.
The largest buyer was Platinum Investment Management, adding an estimated $1.56M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $19.2M sold.
- 73 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q3 2022, up from 57 in Q2 2022.
- Funds reported $101M of Icosavax, Inc. Common Stock stock for Q3 2022, down 46% quarter-over-quarter.
- 21 funds opened new Icosavax, Inc. Common Stock positions in Q3 2022 and 5 closed out, a net change of +16 holders.
- The largest Icosavax, Inc. Common Stock buyer in Q3 2022 was Platinum Investment Management, an estimated $1.56M added.
- The largest Icosavax, Inc. Common Stock seller in Q3 2022 was T. Rowe Price Associates, an estimated $19.2M sold.
Based on aggregated 13F filings for Q3 2022.